Skip to main content

Table 3 Subanalyses according to type of staphylococci

From: Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial

a

 

Success

Failure

Rifampicin group

MSSA

14/18

4/18

MRSE

3/5

2/5

Monotherapy group

MSSA

13/20

7/20

MRSE

5/5

0/5

Total

MSSA

27/38

11/38

MRSE

8/10

2/10

  1. aMSSA methicillin-susceptible S. aureus, MRSE methicillin-resistant S. epidermidis
Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X